Company: SCLXW
Filing Date: 2025-08-04
Form Type: S-1
Source: 0001193125-25-172703
Chunk: 383

Company: Scilex Holding Co
Filing Date: 2025-08-04
Form: S-1
Chunk 383
---
., Ph.D.          |     | $           |  73,125 |     | $      |  42,770 |     |              | — |     | $         | 115,895 |
| Dorman Followwill              |     | $           | 170,545 |     | $      | 131,400 |     |              | — |     | $         | 301,945 |
| Yue Alexander Wu, Ph.D.        |     | $           | 127,500 |     | $      |  42,770 |     |              | — |     | $         | 170,270 |
| Annu Navani, M.D.(3)           |     | $           |       — |     | $      | 239,225 |     |              | — |     | $         | 239,225 |
| Former Non-Employee Director   |     |             |         |     |        |         |     |              |   |     |           |         |
| David Lemus(4)                 |     | $           | 120,000 |     | $      |  88,630 |     |              | — |     | $         | 208,630 |

| (1) | Dr. Ji, our Executive Chairperson, and Mr. Shah, our Chief Executive Officer and President, are not included in this table, as each of them was our employee and therefore receives no compensation for his |

242

| service as a director. Dr. Ji’s and Mr. Shah’s compensation as named executive officers are included in the section titled “Executive and Director Compensation — Summary Compensation Table” above. |

| (2) | As of December 31, 2024, each of our current non-employee directors held options to purchase the following number of shares of our Common Stock: Dr. Chun: 2,857; Mr. Followwill: 5,685; Dr. Wu: 2,857; and Dr. Navani: 7,142. |

| (3) | Dr. Navani was appointed to our Board on July 21, 2024. |

| (4) | Mr. Lemus resigned from our Board effective November 27, 2024. As of December 31, 2024, Lemus held options to purchase 71 shares of our Common Stock. |

Non-Employee Director Compensation Pursuant to our Non-Employee Director Compensation Policy for